Back to News
Mar 4, 2026 4:30 PM

Keros Therapeutics: Q4 Earnings Insights

The Q4 earnings report for Keros Therapeutics (NASDAQ:KROS) was released on Wednesday, March 4, 2026 at 04:01 PM.

Here's what investors need to know about the latest announcement.

Earnings

Keros Therapeutics missed estimated earnings by -82.98%, reporting an EPS of $-0.86 versus an estimate of $-0.47.

Revenue was down $2.66 million from the same period last year.

Earnings History Overview

Last quarter ...